Based on an analysis of mode of action, styrene-induced mouse lung tumors are not a human cancer concern

Area of Science:

• Toxicology
• Carcinogenesis
• Molecular Biology

Background:

• Styrene is a common industrial chemical with established carcinogenicity in mice.
• Previous studies suggested styrene-7,8-oxide (SO) as a potential genotoxic carcinogen.
• The mode of action and human relevance of styrene carcinogenicity required further investigation.

Purpose of the Study:

• To elucidate the mode of action for styrene-induced lung tumors in mice.
• To determine the human relevance of styrene carcinogenicity.
• To assess the cancer risk of styrene exposure to humans.

Main Methods:

• Analysis of 13 chronic rodent studies.
• Investigation of key events in styrene metabolism and toxicity.
• Utilizing CYP2F2 knockout mice and CYP2F1 humanized transgenic mice.
• Comparative analysis of styrene metabolite levels in mouse and human lungs.

Main Results:

• Styrene exposure induced lung tumors in mice but not other organs or in rats.
• Key events included CYP2F2 metabolism in mouse lung, altered gene expression, club cell cytotoxicity, and mitogenesis.
• Styrene-7,8-oxide was not the proximate toxicant, and styrene does not act via a genotoxic mechanism.
• Styrene toxicity was abolished in CYP2F2 knockout and attenuated in CYP2F1 humanized mice.

Conclusions:

• Styrene's mode of action in mice involves specific metabolic activation and cellular events not relevant to humans.
• Limited styrene metabolism and significantly lower SO levels in human lungs indicate a lack of human carcinogenicity.
• Styrene does not present a cancer risk to humans due to species-specific metabolic differences and lack of human epidemiological evidence.